Follow

Submissions from 2019

Link

Surgically Enucleated Gastrointestinal Tumor of the Rectovaginal Septum., Brian H Le, Jasmine Nguyen, Anna Bossert, Tonie Crandall, and Bernice Robinson-Bennett(Article)

Submissions from 2018

Link

Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203., Ann H Klopp, Anamaria R Yeung, Snehal Deshmukh, Karen M Gil, Lari Wenzel, Shannon N Westin, Kent Gifford, David K Gaffney, William Small, Spencer Thompson, Desiree E Doncals, Guilherme H C Cantuaria, Brian P Yaremko, Amy Chang, Vijayananda Kundapur, Dasarahally S Mohan, Michael L Haas, Yong Bae Kim, Catherine L Ferguson, Stephanie L Pugh, Lisa A Kachnic, and Deborah W Bruner(Article)

Submissions from 2017

Link

Obturator Nerve Schwannoma as a Mimic of Ovarian Malignancy., Tyler Gleason, Brian H Le, Kirthik Parthasarathy, and Bernice Robinson-Bennett(Article)

Submissions from 2015

Link

Atypical Glandular Cells of Endometrial Origin and the Risk of Endometrial Cancer., Xuezhi Jiang, Charmaine Anderson, Kathryn E Sharpless, Jessica White, Chevon Alderson, John Demko, Bernice Robinson-Bennett, and Peter F Schnatz(Article)

Submissions from 2013

Link

Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 study., Jeffrey R Infante, Tony R Reid, Allen L Cohn, William J Edenfield, Terrence P Cescon, John T Hamm, Imtiaz A Malik, Thomas A Rado, Philip J McGee, Donald A Richards, Jamal Tarazi, Brad Rosbrook, Sinil Kim, and Thomas H Cartwright(Article)

Link

Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM)., Andra V Krauze, Minhee Won, Christian Graves, Ben W Corn, Thierry M Muanza, Steven P Howard, Arul Mahadevan, Christopher J Schultz, Michael L Haas, Minesh P Mehta, and Kevin A Camphausen(Article)

Link

Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial., Susan V Montgomery, Andrea M Barsevick, Brian L Egleston, Ruth Bingler, Karen Ruth, Suzanne M Miller, John Malick, Terrence P Cescon, and Mary B Daly(Article)

Submissions from 2010

Link

Paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan in the first-line treatment of patients with carcinoma of unknown primary site: a randomized, phase III Sarah Cannon Oncology Research Consortium Trial., John D Hainsworth, David R Spigel, Bobby L Clark, Dianna Shipley, Dana S Thompson, Cynthia Farley, Kimberly West-Osterfield, Cassie M Lane, Terrence P Cescon, Martin J Bury, and F Anthony Greco(Article)

Oxaliplatin plus capecitabine in combination with radiation therapy for treatment of cervical cancer: A phase II study, L Levine(Abstract)

Submissions from 2008

Link

Intention to communicate BRCA1/BRCA2 genetic test results to the family., Andrea M Barsevick, Susan V Montgomery, Karen Ruth, Eric A Ross, Brian L Egleston, Ruth Bingler, John Malick, Suzanne M Miller, Terrence P Cescon, and Mary B Daly(Article)

Link

Implications of tyrosine phosphoproteomics in cervical carcinogenesis., Bernice Robinson-Bennett, James Deford, Concepcion Diaz-Arrastia, Lyuba Levine, Hui-Qui Wang, Edward V Hannigan, and John Papaconstantinou(Article)

Submissions from 2007

Link

A phase II clinical trial of ZD1839 (Iressa) in combination with docetaxel as first-line treatment in patients with advanced breast cancer., Sheri K Dennison, Samuel A Jacobs, John W Wilson, Janell Seeger, Terrence P Cescon, Jane M Raymond, Charles E Geyer, Norman Wolmark, and Sandra M Swain(Article)

Link

Prostate cancer risk assessment program: a 10-year update of cancer detection., Veda N Giri, Jennifer Beebe-Dimmer, Mark Buyyounouski, Andre Konski, Steven J Feigenberg, Robert G Uzzo, Gerald Hanks, Andrew K Godwin, David Y T Chen, Robert Gordon, Terrence P Cescon, Susan Raysor, and Deborah Watkins-Bruner(Article)

Submissions from 2006

Link

Loss of p16 in recurrent malignant mixed müllerian tumors of the uterus., Bernice Robinson-Bennett, R Z Belch, and A C Han(Article)

Submissions from 2005

Pemetrexed/oxaliplatin for first-line treatment of patients with advanced colorectal cancer: a phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program., James N Atkins, Samuel A Jacobs, H Samuel Wieand, Roy E Smith, William J John, Linda H Colangelo, Victor G Vogel, J Philip Kuebler, Terrence P Cescon, Barbara J Miller, Charles E Geyer, and Norman Wolmark(Article)

Submissions from 2001

Link

Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck., M Suntharalingam, Michael L Haas, D A Van Echo, R Haddad, M C Jacobs, S Levy, W C Gray, R A Ord, and B A Conley(Article)

Submissions from 2000

Link

Expression analysis of human HL60 cells exposed to 60 Hz square- or sine-wave magnetic fields., E K Balcer-Kubiczek, G H Harrison, C C Davis, Michael L Haas, and B H Koffman(Article)

Link

The use of concurrent chemotherapy with high-dose radiation before surgical resection in patients presenting with apical sulcus tumors., M Suntharalingam, J R Sonett, Michael L Haas, L A Doyle, P F Hausner, J Schuetz, and M J Krasna(Article)